Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 983Neoplasms 777Carcinoma, Non-Small-Cell Lung 750Prostatic Neoplasms 587Colorectal Neoplasms 508Lung Neoplasms 450Neoplasm Metastasis 413Multiple Myeloma 377Leukemia, Myeloid, Acute 359Ovarian Neoplasms 317Pancreatic Neoplasms 304Melanoma 277Squamous Cell Carcinoma of Head and Neck 261Recurrence 254Carcinoma, Hepatocellular 236Glioblastoma 229Brain Neoplasms 226Head and Neck Neoplasms 204Triple Negative Breast Neoplasms 201Carcinoma, Renal Cell 201Lymphoma 194Precursor Cell Lymphoblastic Leukemia-Lymphoma 193Stomach Neoplasms 189Endometrial Neoplasms 183Lymphoma, Non-Hodgkin 176Sarcoma 171Glioma 168Uterine Cervical Neoplasms 167Lymphoma, Large B-Cell, Diffuse 163Hematologic Neoplasms 163

Interventions

Bumetanide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Unresectable Hepatocellular Carcinoma × 90 days × Clear all
NCT03107416 2026-05-05

Delivering a Diuretic Into the Liver Artery Followed by Plugging up the Artery to Starve Out Liver Cancer Cells

Memorial Sloan Kettering Cancer Center

Phase 1/2 Active not recruiting
30 enrolled
Gastrointestinal

Unresectable Hepatocellular Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡